Cargando…

International validation of a urinary biomarker panel for identification of active lupus nephritis in children

BACKGROUND: Conventional markers of juvenile-onset systemic lupus erythematosus (JSLE) disease activity fail to adequately identify lupus nephritis (LN). While individual novel urine biomarkers are good at detecting LN flares, biomarker panels may improve diagnostic accuracy. The aim of this study w...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Eve Mary Dorothy, Jorgensen, Andrea Lyn, Midgley, Angela, Oni, Louise, Goilav, Beatrice, Putterman, Chaim, Wahezi, Dawn, Rubinstein, Tamar, Ekdawy, Diana, Corkhill, Rachel, Jones, Caroline Ann, Marks, Stephen David, Newland, Paul, Pilkington, Clarissa, Tullus, Kjell, Beresford, Michael William
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5203828/
https://www.ncbi.nlm.nih.gov/pubmed/27590021
http://dx.doi.org/10.1007/s00467-016-3485-3
_version_ 1782489796189356032
author Smith, Eve Mary Dorothy
Jorgensen, Andrea Lyn
Midgley, Angela
Oni, Louise
Goilav, Beatrice
Putterman, Chaim
Wahezi, Dawn
Rubinstein, Tamar
Ekdawy, Diana
Corkhill, Rachel
Jones, Caroline Ann
Marks, Stephen David
Newland, Paul
Pilkington, Clarissa
Tullus, Kjell
Beresford, Michael William
author_facet Smith, Eve Mary Dorothy
Jorgensen, Andrea Lyn
Midgley, Angela
Oni, Louise
Goilav, Beatrice
Putterman, Chaim
Wahezi, Dawn
Rubinstein, Tamar
Ekdawy, Diana
Corkhill, Rachel
Jones, Caroline Ann
Marks, Stephen David
Newland, Paul
Pilkington, Clarissa
Tullus, Kjell
Beresford, Michael William
author_sort Smith, Eve Mary Dorothy
collection PubMed
description BACKGROUND: Conventional markers of juvenile-onset systemic lupus erythematosus (JSLE) disease activity fail to adequately identify lupus nephritis (LN). While individual novel urine biomarkers are good at detecting LN flares, biomarker panels may improve diagnostic accuracy. The aim of this study was to assess the performance of a biomarker panel to identify active LN in two international JSLE cohorts. METHODS: Novel urinary biomarkers, namely vascular cell adhesion molecule-1 (VCAM-1), monocyte chemoattractant protein 1 (MCP-1), lipocalin-like prostaglandin D synthase (LPGDS), transferrin (TF), ceruloplasmin, alpha-1-acid glycoprotein (AGP) and neutrophil gelatinase-associated lipocalin (NGAL), were quantified in a cross-sectional study that included participants of the UK JSLE Cohort Study (Cohort 1) and validated within the Einstein Lupus Cohort (Cohort 2). Binary logistic regression modelling and receiver operating characteristic curve analysis [area under the curve (AUC)] were used to identify and assess combinations of biomarkers for diagnostic accuracy. RESULTS: A total of 91 JSLE patients were recruited across both cohorts, of whom 31 (34 %) had active LN and 60 (66 %) had no LN. Urinary AGP, ceruloplasmin, VCAM-1, MCP-1 and LPGDS levels were significantly higher in those patients with active LN than in non-LN patients [all corrected p values (p (c)) < 0.05] across both cohorts. Urinary TF also differed between patient groups in Cohort 2 (p (c) = 0.001). Within Cohort 1, the optimal biomarker panel included AGP, ceruloplasmin, LPGDS and TF (AUC 0.920 for active LN identification). These results were validated in Cohort 2, with the same markers resulting in the optimal urine biomarker panel (AUC 0.991). CONCLUSION: In two international JSLE cohorts, urinary AGP, ceruloplasmin, LPGDS and TF demonstrate an ‘excellent’ ability for accurately identifying active LN in children. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00467-016-3485-3) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5203828
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-52038282017-01-13 International validation of a urinary biomarker panel for identification of active lupus nephritis in children Smith, Eve Mary Dorothy Jorgensen, Andrea Lyn Midgley, Angela Oni, Louise Goilav, Beatrice Putterman, Chaim Wahezi, Dawn Rubinstein, Tamar Ekdawy, Diana Corkhill, Rachel Jones, Caroline Ann Marks, Stephen David Newland, Paul Pilkington, Clarissa Tullus, Kjell Beresford, Michael William Pediatr Nephrol Original Article BACKGROUND: Conventional markers of juvenile-onset systemic lupus erythematosus (JSLE) disease activity fail to adequately identify lupus nephritis (LN). While individual novel urine biomarkers are good at detecting LN flares, biomarker panels may improve diagnostic accuracy. The aim of this study was to assess the performance of a biomarker panel to identify active LN in two international JSLE cohorts. METHODS: Novel urinary biomarkers, namely vascular cell adhesion molecule-1 (VCAM-1), monocyte chemoattractant protein 1 (MCP-1), lipocalin-like prostaglandin D synthase (LPGDS), transferrin (TF), ceruloplasmin, alpha-1-acid glycoprotein (AGP) and neutrophil gelatinase-associated lipocalin (NGAL), were quantified in a cross-sectional study that included participants of the UK JSLE Cohort Study (Cohort 1) and validated within the Einstein Lupus Cohort (Cohort 2). Binary logistic regression modelling and receiver operating characteristic curve analysis [area under the curve (AUC)] were used to identify and assess combinations of biomarkers for diagnostic accuracy. RESULTS: A total of 91 JSLE patients were recruited across both cohorts, of whom 31 (34 %) had active LN and 60 (66 %) had no LN. Urinary AGP, ceruloplasmin, VCAM-1, MCP-1 and LPGDS levels were significantly higher in those patients with active LN than in non-LN patients [all corrected p values (p (c)) < 0.05] across both cohorts. Urinary TF also differed between patient groups in Cohort 2 (p (c) = 0.001). Within Cohort 1, the optimal biomarker panel included AGP, ceruloplasmin, LPGDS and TF (AUC 0.920 for active LN identification). These results were validated in Cohort 2, with the same markers resulting in the optimal urine biomarker panel (AUC 0.991). CONCLUSION: In two international JSLE cohorts, urinary AGP, ceruloplasmin, LPGDS and TF demonstrate an ‘excellent’ ability for accurately identifying active LN in children. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00467-016-3485-3) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2016-09-03 2017 /pmc/articles/PMC5203828/ /pubmed/27590021 http://dx.doi.org/10.1007/s00467-016-3485-3 Text en © The Author(s) 2016 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Article
Smith, Eve Mary Dorothy
Jorgensen, Andrea Lyn
Midgley, Angela
Oni, Louise
Goilav, Beatrice
Putterman, Chaim
Wahezi, Dawn
Rubinstein, Tamar
Ekdawy, Diana
Corkhill, Rachel
Jones, Caroline Ann
Marks, Stephen David
Newland, Paul
Pilkington, Clarissa
Tullus, Kjell
Beresford, Michael William
International validation of a urinary biomarker panel for identification of active lupus nephritis in children
title International validation of a urinary biomarker panel for identification of active lupus nephritis in children
title_full International validation of a urinary biomarker panel for identification of active lupus nephritis in children
title_fullStr International validation of a urinary biomarker panel for identification of active lupus nephritis in children
title_full_unstemmed International validation of a urinary biomarker panel for identification of active lupus nephritis in children
title_short International validation of a urinary biomarker panel for identification of active lupus nephritis in children
title_sort international validation of a urinary biomarker panel for identification of active lupus nephritis in children
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5203828/
https://www.ncbi.nlm.nih.gov/pubmed/27590021
http://dx.doi.org/10.1007/s00467-016-3485-3
work_keys_str_mv AT smithevemarydorothy internationalvalidationofaurinarybiomarkerpanelforidentificationofactivelupusnephritisinchildren
AT jorgensenandrealyn internationalvalidationofaurinarybiomarkerpanelforidentificationofactivelupusnephritisinchildren
AT midgleyangela internationalvalidationofaurinarybiomarkerpanelforidentificationofactivelupusnephritisinchildren
AT onilouise internationalvalidationofaurinarybiomarkerpanelforidentificationofactivelupusnephritisinchildren
AT goilavbeatrice internationalvalidationofaurinarybiomarkerpanelforidentificationofactivelupusnephritisinchildren
AT puttermanchaim internationalvalidationofaurinarybiomarkerpanelforidentificationofactivelupusnephritisinchildren
AT wahezidawn internationalvalidationofaurinarybiomarkerpanelforidentificationofactivelupusnephritisinchildren
AT rubinsteintamar internationalvalidationofaurinarybiomarkerpanelforidentificationofactivelupusnephritisinchildren
AT ekdawydiana internationalvalidationofaurinarybiomarkerpanelforidentificationofactivelupusnephritisinchildren
AT corkhillrachel internationalvalidationofaurinarybiomarkerpanelforidentificationofactivelupusnephritisinchildren
AT jonescarolineann internationalvalidationofaurinarybiomarkerpanelforidentificationofactivelupusnephritisinchildren
AT marksstephendavid internationalvalidationofaurinarybiomarkerpanelforidentificationofactivelupusnephritisinchildren
AT newlandpaul internationalvalidationofaurinarybiomarkerpanelforidentificationofactivelupusnephritisinchildren
AT pilkingtonclarissa internationalvalidationofaurinarybiomarkerpanelforidentificationofactivelupusnephritisinchildren
AT tulluskjell internationalvalidationofaurinarybiomarkerpanelforidentificationofactivelupusnephritisinchildren
AT beresfordmichaelwilliam internationalvalidationofaurinarybiomarkerpanelforidentificationofactivelupusnephritisinchildren